No abstract

A dual-beam detection strategy with automatic balancing is described for ultrasensitive spectroscopy. Absorbances of 2 × 10(-7) Hz(-½) in free-space configurations and 5 × 10(-6) Hz(-½) in fiber-coupled configurations are demonstrated. With the dual-beam technique, atmospherically broadened absorption transitions may be resolved with InGaAsP, AlGaAs, and AlGaInP single-longitudinal-mode diode lasers. Applications to trace measurements of NO(2), O(2), and H(2)O are described by the use of simple, inexpensive laser and detector systems. Small signal gain measurements on optically pumped I(2) with a sensitivity of 10(-5) are also reported.

The optically pumped rare-gas metastable laser is a chemically inert analogue to three-state optically pumped alkali laser systems. The concept requires efficient generation of electronically excited metastable atoms in a continuous-wave (CW) electric discharge in flowing gas mixtures near atmospheric pressure. We have observed CW optical gain and laser oscillation at 912.3 nm using a linear micro-discharge array to generate metastable Ar(4s, 1s(5)) atoms at atmospheric pressure. We observed the optical excitation of the 1s(5) → 2p(9) transition at 811.5 nm and the corresponding fluorescence, optical gain and laser oscillation on the 2p(10) ↔ 1s(5) transition at 912.3 nm, following 2p(9)→2p(10) collisional energy transfer. A steady-state kinetics model indicates efficient collisional coupling within the Ar(4s) manifold.

Abstract. Photodynamic therapy ͑PDT͒ is a viable treatment option for a wide range of applications, including oncology, dermatology, and ophthalmology. Singlet oxygen is believed to play a key role in the efficacy of PDT, and on-line monitoring of singlet oxygen during PDT could provide a methodology to establish and customize the treatment dose clinically. This work is the first report of monitoring singlet oxygen luminescence in vivo in human subjects during PDT, demonstrating the correlation of singlet oxygen levels during PDT with the post-PDT photobiological response. Photodynamic therapy ͑PDT͒ is a viable treatment option for a variety of applications, including oncology, dermatology, and ophthalmology.1 In particular, 5-aminolevulinic acid ͑ALA͒-PDT is widely used to treat a range of dermatologic conditions.2 PDT is based on the interaction of a photosensitizer ͑PS͒, light, and oxygen, in which photoactivation of PS generates cytotoxic molecular species. Customized dosimetry could, in principle, impact the efficacy of treatment outcome and of the effective use of resources. Dosimetry in PDT is complex, as the treatment effect is generated by an interaction of multiple components.

No abstract